Molecular Oncology
Volume 2, Issue 3 , Pages 272-281 , October 2008

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

  • Oliver Hantschel

      Affiliations

    • Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 19, 1090 Vienna, Austria
    • O.H. and A.G. contributed equally to this study.
  • ,
  • Agnes Gstoettenbauer

      Affiliations

    • Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 19, 1090 Vienna, Austria
    • O.H. and A.G. contributed equally to this study.
  • ,
  • Jacques Colinge

      Affiliations

    • Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 19, 1090 Vienna, Austria
  • ,
  • Ines Kaupe

      Affiliations

    • Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 19, 1090 Vienna, Austria
  • ,
  • Martin Bilban

      Affiliations

    • Department of Laboratory Medicine, Medical University of Vienna and Ludwig Boltzmann Institute for Clinical and Experimental Oncology, Währinger Gürtel 18–20, 1090 Vienna, Austria
  • ,
  • Thomas R. Burkard

      Affiliations

    • Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 19, 1090 Vienna, Austria
  • ,
  • Peter Valent

      Affiliations

    • Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Währinger Gürtel 18–20, 1090 Vienna, Austria
  • ,
  • Giulio Superti-Furga

      Affiliations

    • Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 19, 1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 40160 70001; fax: +43 1 40160 970000.

Received 3 June 2008 ,Revised 15 July 2008 ,Accepted 16 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1574-7891(08)00093-8

doi: 10.1016/j.molonc.2008.07.003

Molecular Oncology
Volume 2, Issue 3 , Pages 272-281 , October 2008